| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.50B | +7.6% |
| Cost of Revenue | $478.5M | +7.7% |
| Gross Profit | $2.02B | +7.6% |
| R&D Expense | $936.5M | +5.0% |
| SG&A Expense | $237.1M | +6.4% |
| Operating Income | $538.7M | +197.1% |
| Pre-tax Income | $554.4M | +187.7% |
| Income Tax | $100.8M | +128.0% |
| Net Income | $453.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $614.9M | +164.1% |
| Accounts Receivable | $68.7M | +27.7% |
| Current Assets | $1.52B | +1.8% |
| Total Assets | $2.98B | -4.1% |
| Current Liabilities | $1.20B | +0.4% |
| Total Liabilities | $3.15B | -7.9% |
| Stockholders' Equity | -$165.8M | +46.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $783.7M | -1.7% |
| Capital Expenditures | $24.3M | -28.1% |
| Investing Cash Flow | $395.2M | +914.8% |
| Financing Cash Flow | -$799.2M | +23.3% |
| Free Cash Flow | $759.4M | -0.5% |
| -18.0% |
| EPS (Basic) | $1.33 | -13.1% |
| EPS (Diluted) | $1.31 | -13.8% |